Innovus Pharmaceuticals - M&A Summary, Ownership, and Business Overview

Medical ProductsCompany

Innovus Pharmaceuticals M&A Summary

Innovus Pharmaceuticals has acquired 3 companies of its own.

Innovus Pharmaceuticals’ largest acquisition to date was in 2016, when it acquired Beyond Human for $630K. Innovus Pharmaceuticals has acquired in 3 different US states. The Company’s most targeted sectors include consumer products (34%) and e-commerce (34%).

Innovus Pharmaceuticals Ownership

Who owns Innovus Pharmaceuticals?

Innovus Pharmaceuticals is owned by Aytu BioScience. It was acquired on September 12, 2019.

Innovus Pharmaceuticals Business Overview

Where is Innovus Pharmaceuticals headquartered?

Innovus Pharmaceuticals is headquartered in San Diego, California.

What is Innovus Pharmaceuticals’ revenue?

Innovus Pharmaceuticals disclosed revenue of 24M USD for 2018 and 9M USD for 2017.

How many employees does Innovus Pharmaceuticals have?

Innovus Pharmaceuticals has 27 employees.

What sector is Innovus Pharmaceuticals in?

Innovus Pharmaceuticals is a medical products company.

When was Innovus Pharmaceuticals founded?

Innovus Pharmaceuticals was founded in 2011.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 3
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Innovus Pharmaceuticals, Inc.

8845 Rehco Road,
San Diego, California 92122
United States,
(858) 964-5123
www.innovuspharma.com

Innovus Pharmaceuticals, Inc. is a pharmaceutical company. The company produces consumer products for men's and women's health and vitality. The company generates revenues from its lead products Zestra(R) for female arousal and EjectDelay(R) for premature ejaculation and has a total of five marketed products in this space. Innovus Pharmaceuticals was founded in 2008 and is based in San Diego, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
vol $630K $630K
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
SupplementHunt 2018-12-14 - Add-on Acquisition
Boston, Massachusetts · www.supplementhunt.com
Beyond Human LLC 2016-03-01 630K USD Add-on Acquisition
Austin, Texas · www.beyondhumantestosterone.com
Semprae Laboratories, Inc. 2013-12-24 - Divestiture
Saddle Brook, New Jersey · www.zestra.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Consumer Products 1 (33%) 630K (100%) - -
E-Commerce 1 (33%) - - -
Medical Products 1 (33%) - - -
Total 3 $630K - -

By Geo

State/Country Buy Value Sell Value
United States 3 630K - -
  Texas 1 630K - -
  New Jersey 1 - - -
  Massachusetts 1 - - -
Total 3 $630K - -

Deal Values

buy # Total
< $100M 1 $630K
TOTAL $630K
Largest Beyond Human LLC
$630K (2016-03-01)

M&A Connections

Deals
Acquired from
Strategic(s)
33%
1 (33%)

 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.